Reduced apoptosis rates in human schwannomas

Brain Pathology

Volumn 15, Issue 1, 2005, Pages 17-22

  Utermark, Tamara ^a   Kaempchen, Katherine ^a   Antoniadis, Gregor ^a   Hanemann, C Oliver ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; MERLIN;

APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL CULTURE; CELL SURVIVAL; GENE MUTATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MENINGIOMA; NERVE; NEURILEMOMA; NEURINOMA; NEUROFIBROMATOSIS; NICK END LABELING; SCHWANN CELL; STATISTICAL ANALYSIS; TUMOR; TUMOR SUPPRESSOR GENE;

EID: 13544259950     PISSN: 10156305     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2005.tb00095.x     Document Type: Article

References (37)

1. (1994) National Institutes of Health Consensus Development Conference Statement on Acoustic Neuroma, December 11-13, 1991. The Consensus Development Panel. Arch Neurol 51:201-207.
2. Abend M (2003) Reasons to reconsider the significance of apoptosis for cancer therapy. Int J Radiat Biol 79:927-941.
3. Bijisma EK, Brouwer-Mladin R, Bosch DA, sterveld A, Hulsebos TJM (1992) Molecular characterization of chromosome 22 deletions in schwannomas. Genes Chromosomes Cancer 5:201-205.
4. Chen S, Rio C, Ji RR, Dikkes P, Coggeshall RE, Woolf CJ, Corfas G (2003) Disruption of ErbB receptor signaling in adult non-myelinating Schwann cells causes progressive sensory loss. Nat Neurosci 6:1186-1193.
5. Cheng HL, Steinway ML, Xin X, Feldman EL (2001) Insulin-like growth factor-I and Bcl-X(L) inhibit c-jun N-terminal kinase activation and rescue Schwann cells from apoptosis. J Neurochem 76:935-943.
6. Dowsing BJ, Morrison WA, Nicola NA, Starkey GP, Bucci T, Kilpatrick TJ (1999) Leukemia inhibitory factor is an autocrine survival factor for Schwann cells. J Neurochem 73:96-104.
7. Fawcett JW, Keynes RJ (1990) Peripheral nerve regeneration. Annu Rev Neurosci 13:43-60.
8. Grinspan JB, Marchionni MA, Reeves M, Coulaloglou M, Scherer SS (1996) Axonal interactions regulate Schwann cell apoptosis in developing peripheral nerve: neuregulin receptors and the role of neuregulins. J Neurosci 16:6107-6118.
9. Hagel C, Lindenau M, Lamszus K, Kluwe L, Stavrou D, Mautner VF (2002) Polyneuropathy in neurofibromatosis 2: clinical findings, molecular genetics and neuropathological alterations in sural nerve biopsy specimens. Acta Neuropathol (Berl) 104:179-187.
10. Hanemann CO, Rosenbaum C, Kupfer S, Wosch S, Stoegbauer F, Mueller HW (1998) Improved culture methods to expand Schwann cells with altered growth behaviour from CMT1A patients. GLIA 23:89-98.
11. Hochedlinger K, Wagner EF, Sabapathy K (2002) Differential effects of JNK1 and JNK2 on signal specific induction of apoptosis. Oncogene 21:2441-2445.
12. Kaempchen K, Mielke K, Utermark T, Langmesser S, Hanemann CO (2003) Upregulation of the Rac1/JNK signaling pathway in primary human schwannoma cells. Hum Mol Genetics 12:1211-1221.
13. Kimura Y, Saya H, Nakao M (2000) Calpain-dependent proteolysis of NF2 protein: involvement in schwannomas and meningiomas. Neuropathology 20:153-160.
14. Kuan CY, Yang DD, Samanta Roy DR, Davis RJ, Rakic P, Flavell RA (1999) The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development. Neuron 22:667-676.
15. Lin A, Dibling B (2002) The true face of JNK activation in apoptosis. Aging Cell 1:112-116.
16. Meier C, Parmantier E, Brennan A, Mirsky R, Jessen KR (1999) Developing Schwann cells acquire the ability to survive without axons by establishing an autocrine circuit involving insulin-like growth factor, neurotrophin-3, and platelet-derived growth factor-BB. J Neurosci 19:3847-3859.
17. Mendenhall WM, Friedman WA, Amdur RJ, Antonelli PJ (2004) Management of acoustic schwannoma. Am J Otolaryngol 25:38-47.
18. Morrison H, Sherman LS, Legg J, Banine F, Isacke C, Haipek CA, Gutmann DH, Ponta H, Herrlich P (2001) The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44. Genes Dev 15:968-980.
19. Pelton PD, Sherman LS, Rizvi TA, Marchionni MA, Wood P, Friedman RA, Ratner N (1998) Ruffling membrane, stress fiber, cell spreading and proliferation abnormalities in human Schwannoma cells. Oncogene 17:2195-2209.
20. Petratos S, Butzkueven H, Shipham K, Cooper H, Bucci T, Reid K, Lopes E, Emery B, Cheema SS, Kilpatrick TJ (2003) Schwann cell apoptosis in the postnatal axotomized sciatic nerve is mediated via NGF through the low-affinity neurotrophin receptor. J Neuropathol Exp Neurol 62:398-411.
21. Rosenbaum C, Kluwe L, Mautner VF, Friedrich RE, Mueller HW, Hanemann CO (1998) Isolation and characterization of Schwann cells from neurofibromatosis type 2 patients. Neurobiol Dis 5:55-64.
22. Rouleau GA, Merel P, Lutchman M, Sanson M, Zucman J, Marineau C, Hoang-Xuan K, Demczuk S, Desmaze C, Plougastel B (1993) Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2 (see comments). Nature 363:515-521.
23. Rowe JG, Radatz MW, Walton L, Hampshire A, Seaman S, Kemeny AA (2003) Gamma knife stereotactic radiosurgery for unilateral acoustic neuromas. J Neurol Neurosurg Psychiatry 74:1536-1542.
24. Sainio M, Zhao F, Heiska L, Turunen O, den Bakker M, Zwarthoff E, Lutchman M, Rouleau GA, Jaaskelainen J, Vaheri A, Carpen O (1997) Neurofibromatosis 2 tumor suppressor protein colocalizes with ezrin and CD44 and associates with actin-containing cytoskeleton. J Cell Sci 110 (Pt 18):2249-2260.
25. Sainz J, Huynh DP, Figueroa K, Ragge NK, Baser ME, Pulst SM (1994) Mutations of the neurofibromatosis type 2 gene and lack of the gene product in vestibular schwannomas. Hum Mol Genetics 3:885-891.
26. Schulze KM, Hanemann CO, Muller HW, Hanenberg H (2002) Transduction of wild-type merlin into human schwannoma cells decreases schwannoma cell growth and induces apoptosis. Hum Mol Genetics 11:69-76.
27. Sherman L, Jacoby LB, Lampe J, Pelton P, Aguzzi A, Herrlich P, Ponta H (1997) CD44 expression is aberrant in benign Schwann cell tumors possessing mutations in the neurofibromatosis type 2, but not type 1, gene. Cancer Res 57:4889-4897.
28. Sherman LS, Rizvi TA, Karyala S, Ratner N (2000) CD44 enhances neuregulin signaling by Schwann cells. J Cell Biol 150:1071-1084.
29. Sperfeld AD, Hein C, Schroder JM, Ludolph AC, Hanemann CO (2002) Occurrence and characterization of peripheral nerve involvement in neurofibromatosis type 2. Brain 125:996-1004.
30. Syroid DE, Maycox PR, Burrola PG, Liu N, Wen D, Lee KF, Lemke G, Kilpatrick TJ (1996) Cell death in the Schwann cell lineage and its regulation by neuregulin. Proc Natl Acad Sci USA 93:9229-9234.
31. Syroid DE, Zorick TS, Arbet-Engels C, Kilpatrick TJ, Eckhart W, Lemke G (1999) A role for insulin-like growth factor-I in the regulation of Schwann cell survival. J Neurosci 19:2059-2068.
32. Takeuchi K, Sato N, Kasahara H, Funayama N, Nagafuchi A, Yonemura S, Tsukita S, Tsukita S (1994) Perturbation of cell adhesion and microvilli formation by antisense oligonucleotides to ERM family members. J Cell Biol 125:1371-1384.
33. Trachtenberg JT, Thompson WJ (1996) Schwann cell apoptosis at developing neuromuscular junctions is regulated by glial growth factor. Nature 379:174-177.
34. Trofatter JA, MacCollin MM, Rutter JL, Murrell JR, Duyao MP, Parry DM, Eldridge R, Kley N, Menon AG, Pulaski K (1993) A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 75:826-.
35. Utermark T, Kaempchen K, Hanemann CO (2003) Pathological adhesion of primary human schwannoma cells is dependent on altered expression of integrins. Brain Pathol 13:352-363.
36. Wisdom R, Johnson RS, Moore C (1999) c-Jun regulates cell cycle progression and apoptosis by distinct mechanisms. EMBO J 18:188-197.
37. Wolff RK, Frazer KA, Jackler RK, Lanser MJ, Pitts LH, Cox DR (1992) Analysis of chromosome 22 deletions in neurofibromatosis type 2-related tumors. Am J Hum Genetics 51:478-485.